Skip to main content
. 2023 Jun 3;2023:4413049. doi: 10.1155/2023/4413049

Table 3.

A multivariate and univariate Cox proportional hazards analysis of TMEM147 expression in HCC.

Characteristics Total (N) Univariate analysis Multivariate analysis
Hazard ratio (95% CI) P value Hazard ratio (95% CI) P value
T stage (T2 & T3 & T4 vs. T1) 370 2.126 (1.481–3.052) <0.001 1.433 (0.798–2.574) 0.228
N stage (N0 vs. N1) 258 2.029 (0.497–8.281) 0.324
M stage (M1 vs. M0) 272 4.077 (1.281–12.973) 0.017 1.208 (0.287–5.079) 0.797
Pathologic stage (Stage I & Stage II vs. Stage III & Stage IV) 349 2.504 (1.727–3.631) <0.001 1.944 (1.128–3.351) 0.017
Tumor status (tumor free vs. with tumor) 354 2.317 (1.590–3.376) <0.001 1.977 (1.239–3.155) 0.004
Gender (female vs. male) 373 0.793 (0.557–1.130) 0.2
Race (White vs. Black or African American) 361 0.791 (0.551–1.135) 0.203
Age (≤0 vs. >60) 373 1.205 (0.850–1.708) 0.295
Weight (≤70 vs. >70) 345 0.941 (0.657–1.346) 0.738
BMI (≤25 vs. >25) 336 0.798 (0.550–1.158) 0.235
Histologic grade (G1 & G2 vs.G3 & G4) 368 1.091 (0.761–1.564) 0.636
AFP (ng/ml) (≤400 vs. >400) 279 1.075 (0.658–1.759) 0.772
Vascular invasion (no vs. yes) 317 1.344 (0.887–2.035) 0.163
Fibrosis Ishak score (0 & 1/2 vs. 3/4 & 5/6) 214 0.740 (0.445–1.232) 0.247
Adjacent hepatic tissue inflammation (none vs. mild & severe) 236 1.194 (0.734–1.942) 0.475
TMEM147 (low vs. high) 373 2.079 (1.458–2.966) <0.001 2.121 (1.336–3.369) 0.001

TMEM147: transmembrane protein 14.